HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

France’s Prime Minister Wades Into Liberalisation Debate, Claiming Online Restrictions Have Gone “Too Far”

Executive Summary

France's Prime Minister Edouard Philippe intervenes in the debate over whether to liberalize the country's still very traditional pharmacy market. 

You may also be interested in...



France Should Allow Supermarket Sale Of OTCs And Relax Pharmacy Ownership Rules, Says Competition Authority

The French competition authority recommends OTC sales should be permitted outside pharmacy, while more should be done to promote online sales. Furthermore, pharmacy ownership restrictions should be relaxed, the authority says in its wide ranging enquiry into competition in the country's medicines sector.

France's Supplement Market in 2018: Demand For Probiotics and Natural Alternatives Drives Sales Growth

France's food supplements market enjoyed broad-based growth across key categories in 2018, driven by consumer demand for natural alternatives to conventional medicine. Over the 12 months, Pileje overtook Arkopharma as the dominant player in market, as its leading probiotics brand, Symbiosys, flew off the shelves.

France's OTC Market in 2018: Self-Medication Sales Slump, Sanofi Claims Number-One Spot

France's self-medication market had a difficult 2018, due to a weak flu season and changing dynamics in the sector, according to industry association Afipa. Despite this it was a good year for Sanofi, which overtook Boiron as the number-one OTC firm in the market, while its Doliprane analgesic became France's best-selling brand.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148615

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel